Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Veterinary/Animal Vaccines market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Veterinary/Animal Vaccines market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
Segmented by End User/Segment
Hospitals and Clinics
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Zoetis
Virbac
Vetoquinol
Tianjin Ringpu
Phibro Animal Health
Merck Animal Health
Idt Biologika
Hipra
Hester
Elanco
China Animal Husbandry
Boehringer Ingelheim
Biogenesis Bago
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Veterinary/Animal Vaccines Market Status and Forecast (2016-2027) 1.3.2 Global Veterinary/Animal Vaccines Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Veterinary/Animal Vaccines Supply by Company 2.1 Global Veterinary/Animal Vaccines Sales Volume by Company 2.2 Global Veterinary/Animal Vaccines Sales Value by Company 2.3 Global Veterinary/Animal Vaccines Price by Company 2.4 Veterinary/Animal Vaccines Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Veterinary/Animal Vaccines Market Status by Category 3.1 Veterinary/Animal Vaccines Category Introduction 3.1.1 Live Attenuated Vaccines 3.1.2 Inactivated Vaccines 3.1.3 Toxoid Vaccines 3.1.4 Recombinant Vaccines 3.1.5 Other Vaccines 3.2 Global Veterinary/Animal Vaccines Market by Category 3.2.1 Global Veterinary/Animal Vaccines Sales Volume by Category (2016-2021) 3.2.2 Global Veterinary/Animal Vaccines Sales Value by Category (2016-2021) 3.2.3 Global Veterinary/Animal Vaccines Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Veterinary/Animal Vaccines Market Status by End User/Segment 4.1 Veterinary/Animal Vaccines Segment by End User/Segment 4.1.1 Hospitals and Clinics 4.1.2 Others 4.2 Global Veterinary/Animal Vaccines Market by End User/Segment 4.2.1 Global Veterinary/Animal Vaccines Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Veterinary/Animal Vaccines Sales Value by End User/Segment (2016-2021) 4.2.3 Global Veterinary/Animal Vaccines Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Veterinary/Animal Vaccines Market Status by Region 5.1 Global Veterinary/Animal Vaccines Market by Region 5.1.1 Global Veterinary/Animal Vaccines Sales Volume by Region 5.1.2 Global Veterinary/Animal Vaccines Sales Value by Region 5.2 North America Veterinary/Animal Vaccines Market Status 5.3 Europe Veterinary/Animal Vaccines Market Status 5.4 Asia Pacific Veterinary/Animal Vaccines Market Status 5.5 Central & South America Veterinary/Animal Vaccines Market Status 5.6 Middle East & Africa Veterinary/Animal Vaccines Market Status6 North America Veterinary/Animal Vaccines Market Status 6.1 North America Veterinary/Animal Vaccines Market by Country 6.1.1 North America Veterinary/Animal Vaccines Sales Volume by Country (2016-2021) 6.1.2 North America Veterinary/Animal Vaccines Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Veterinary/Animal Vaccines Market Status 7.1 Europe Veterinary/Animal Vaccines Market by Country 7.1.1 Europe Veterinary/Animal Vaccines Sales Volume by Country (2016-2021) 7.1.2 Europe Veterinary/Animal Vaccines Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Veterinary/Animal Vaccines Market Status 8.1 Asia Pacific Veterinary/Animal Vaccines Market by Country 8.1.1 Asia Pacific Veterinary/Animal Vaccines Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Veterinary/Animal Vaccines Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Veterinary/Animal Vaccines Market Status 9.1 Central & South America Veterinary/Animal Vaccines Market by Country 9.1.1 Central & South America Veterinary/Animal Vaccines Sales Volume by Country (2016-2021) 9.1.2 Central & South America Veterinary/Animal Vaccines Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Veterinary/Animal Vaccines Market Status 10.1 Middle East & Africa Veterinary/Animal Vaccines Market by Country 10.1.1 Middle East & Africa Veterinary/Animal Vaccines Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Veterinary/Animal Vaccines Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Veterinary/Animal Vaccines Manufacturing Cost Analysis 11.5 Veterinary/Animal Vaccines Sales Channel and Distributors Analysis 11.5.1 Veterinary/Animal Vaccines Sales Channel 11.5.2 Veterinary/Animal Vaccines Distributors 11.6 Veterinary/Animal Vaccines Downstream Major Buyers12 Global Veterinary/Animal Vaccines Market Forecast by Category and by End User/Segment 12.1 Global Veterinary/Animal Vaccines Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Veterinary/Animal Vaccines Forecast by Category 12.2.1 Global Veterinary/Animal Vaccines Sales Volume Forecast by Category 12.2.2 Global Veterinary/Animal Vaccines Sales Value Forecast by Category 12.2.3 Global Veterinary/Animal Vaccines Price Forecast by Category 12.3 Global Veterinary/Animal Vaccines Forecast by End User/Segment 12.3.1 Global Veterinary/Animal Vaccines Sales Volume Forecast by End User/Segment 12.3.2 Global Veterinary/Animal Vaccines Sales Value Forecast by End User/Segment 12.3.3 Global Veterinary/Animal Vaccines Price Forecast by End User/Segment13 Global Veterinary/Animal Vaccines Market Forecast by Region/Country 13.1 Global Veterinary/Animal Vaccines Market Forecast by Region (2022-2027) 13.1.1 Global Veterinary/Animal Vaccines Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Veterinary/Animal Vaccines Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Zoetis 14.1.1 Company Information 14.1.2 Veterinary/Animal Vaccines Product Introduction 14.1.3 Zoetis Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Virbac 14.2.1 Company Information 14.2.2 Veterinary/Animal Vaccines Product Introduction 14.2.3 Virbac Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Vetoquinol 14.3.1 Company Information 14.3.2 Veterinary/Animal Vaccines Product Introduction 14.3.3 Vetoquinol Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Tianjin Ringpu 14.4.1 Company Information 14.4.2 Veterinary/Animal Vaccines Product Introduction 14.4.3 Tianjin Ringpu Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Phibro Animal Health 14.5.1 Company Information 14.5.2 Veterinary/Animal Vaccines Product Introduction 14.5.3 Phibro Animal Health Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Merck Animal Health 14.6.1 Company Information 14.6.2 Veterinary/Animal Vaccines Product Introduction 14.6.3 Merck Animal Health Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Idt Biologika 14.7.1 Company Information 14.7.2 Veterinary/Animal Vaccines Product Introduction 14.7.3 Idt Biologika Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Hipra 14.8.1 Company Information 14.8.2 Veterinary/Animal Vaccines Product Introduction 14.8.3 Hipra Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Hester 14.9.1 Company Information 14.9.2 Veterinary/Animal Vaccines Product Introduction 14.9.3 Hester Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Elanco 14.10.1 Company Information 14.10.2 Veterinary/Animal Vaccines Product Introduction 14.10.3 Elanco Veterinary/Animal Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 China Animal Husbandry 14.12 Boehringer Ingelheim 14.13 Biogenesis Bago15 Conclusion16 Methodology